Currently, the pre-clinical field is rapidly progressing in search of new therapeutic modalities that replace or complement current medication to treat cardiovascular disease. Among these are the single or combined use of stem cells, biomaterials and instructive factors, which together form the triad of tissue engineering and regenerative medicine. Stem cell therapy is a promising approach for repair, remodeling and even regenerate tissue of otherwise irreparable damage, such as after myocardial infarction (aMI) and Aortic aneurysm. A severe limitation of cardiac stem cell therapy is the generally poor retention of administered cells in the target tissue. In tissue repair, the main mode of action of adipose tissue-derived stem cells (ADSC) ...
Recent efforts have made in order to novel therapeutic approaches to reduce the heavy cardiovascular...
Myocyte loss due to ischemia/reperfusion injury leads to cardiac dysfunction and heart failure, and ...
Myocardial infarction causes cardiac tissue damage and the release of damage-associated molecular pa...
Currently, the pre-clinical field is rapidly progressing in search of new therapeutic modalities tha...
Cardiovascular diseases are the leading cause of death globally. Myocardial Infarction occurs due to...
Coronary (CAD) and peripheral (PAD) artery diseases are major causes of morbidity and mortality, and...
Experimental studies have shown that cardiac transfer of unfractionated or partially purified bone m...
The use of stem and progenitor cells in cardiovascular therapy has been proposed as a feasible optio...
Along with angiogenesis and gene therapy, stem cell transplantation is one of the newest treatment m...
The primary cause of death among chronic diseases worldwide is ischemic cardiovascular diseases, suc...
Adipose tissue is emerging as an advantageous source of adult stem cells, with potential utility for...
Stem cell biology has increasingly gained scientific and public interest in recent years. In particu...
Coronary (CAD) and peripheral (PAD) artery diseases are major causes of morbidity and mortality, and...
Adipose-derived stem cells (ADSCs) can maintain self-renewal and enhanced multidifferentiation poten...
Introduction: Stem cell-based therapies represent a valid approach to restore cardiac function due t...
Recent efforts have made in order to novel therapeutic approaches to reduce the heavy cardiovascular...
Myocyte loss due to ischemia/reperfusion injury leads to cardiac dysfunction and heart failure, and ...
Myocardial infarction causes cardiac tissue damage and the release of damage-associated molecular pa...
Currently, the pre-clinical field is rapidly progressing in search of new therapeutic modalities tha...
Cardiovascular diseases are the leading cause of death globally. Myocardial Infarction occurs due to...
Coronary (CAD) and peripheral (PAD) artery diseases are major causes of morbidity and mortality, and...
Experimental studies have shown that cardiac transfer of unfractionated or partially purified bone m...
The use of stem and progenitor cells in cardiovascular therapy has been proposed as a feasible optio...
Along with angiogenesis and gene therapy, stem cell transplantation is one of the newest treatment m...
The primary cause of death among chronic diseases worldwide is ischemic cardiovascular diseases, suc...
Adipose tissue is emerging as an advantageous source of adult stem cells, with potential utility for...
Stem cell biology has increasingly gained scientific and public interest in recent years. In particu...
Coronary (CAD) and peripheral (PAD) artery diseases are major causes of morbidity and mortality, and...
Adipose-derived stem cells (ADSCs) can maintain self-renewal and enhanced multidifferentiation poten...
Introduction: Stem cell-based therapies represent a valid approach to restore cardiac function due t...
Recent efforts have made in order to novel therapeutic approaches to reduce the heavy cardiovascular...
Myocyte loss due to ischemia/reperfusion injury leads to cardiac dysfunction and heart failure, and ...
Myocardial infarction causes cardiac tissue damage and the release of damage-associated molecular pa...